Value co-creation in healthcare: Evidence from innovative therapeutic alternatives for hereditary angioedema

被引:0
作者
Spanò R. [1 ]
Di Paola N. [1 ]
Bova M. [2 ]
Barbarino A. [3 ]
机构
[1] Department of Economics, Management, Institutions, University of Naples Federico II, Campus Universitario di Monte S. Angelo, Via Cintia 24, Naples
[2] Department of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini 5, Naples
[3] Department of Public Health, University of Naples Federico II, Via S. Pansini 5, Naples
关键词
C1-INH-HAE; Compliance; Payer perspective; Service-dominant logic; Societal perspective; Value co-creation;
D O I
10.1186/s12913-018-3389-y
中图分类号
学科分类号
摘要
Background: Our research focuses on the co-creation of value in healthcare with reference to a case of hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE). Our work is mainly based on the concept of value co-creation in healthcare. The aim of this study is to assess the impact of an alternative treatment strategy - self-administration - by focusing on treatment outcomes and costs to understand if innovative therapeutic solutions can create value for patients and healthcare systems. Methods: This paper compares home-based and hospital-based therapeutic strategies (independent of treatment type) with a cost minimization analysis. It encompasses compliance issues and focuses on both payer and societal perspectives, also benefiting from an operationalization of the service-dominant logic model for healthcare delivery. Data were collected over a 6-month period (August 2014-January 2015) through monthly patient interviews. Archival data were used for variable measurement. Results: Thirty-nine out of 62 patients enrolled in the study, experienced at least one HAE attacks, equally distributed between home and hospital-based strategies. No evidence of correlation between therapeutic strategy and disease severity score (p = 0.351), compliance (p = 0.399), and quality of life (p = 0.971), were found. Total direct cost per attack amounts to € 1224 for home-based strategy with respect to € 1454 for hospital-based strategy, with a savings of € 230. The economic advantage of the home-based strategy almost doubles if the societal perspective was considered due to a further savings of €169 (less missed work/school days and no travel expenses). Conclusions: Our study suggests that home-based therapies represent a feasible strategy for managing C1-INH-HAE and may result in lower costs and increased value for both patients and the healthcare systems. The findings are relevant to the debate on and extend the extant literature to provide a broader view of value co-creation dynamics for home-based therapies in healthcare and their positive effects. The insights are relevant to practitioners and policy makers. © 2018 The Author(s).
引用
收藏
相关论文
共 73 条
[21]  
Gronroos C., Conceptualising value co-creation: A journey to the 1970s and back to the future, J Mark Manag, (2012)
[22]  
Galvagno M., Dalli D., Theory of value co-creation: A systematic literature review, Manag Serv Qual, (2014)
[23]  
McHugh M., Harvey J.B., Kang R., Shi Y., Scanlon D.P., Community-level quality improvement and the patient experience for chronic illness care, Health Serv Res, (2016)
[24]  
Lee K.H.K., Austin J.M., Pronovost P.J., Developing a measure of value in health care, Value Health, (2016)
[25]  
Wegner S.E., Measuring value in health care: The times, they are a changing, N C Med J., (2016)
[26]  
Gronroos C.V., Critical service logic: Making sense of value creation and co-creation, J Acad Mark Sci., (2013)
[27]  
Gronroos C.R., Service as business logic: Implications for value creation and marketing, J Serv Manag, (2011)
[28]  
Gummerus J., Value creation processes and value outcomes in marketing theory: Strangers or siblings?, Mark Theory, (2013)
[29]  
Prahalad Ck Ramaswamy V., Co-creation experiences: The next practice in value creation, J Interact Mark, (2004)
[30]  
Vargo S.L., Lusch R.F., Evolving to a new dominant logic for marketing, J Mark, (2004)